Effect of Phytovagex vaginal suppository on Bacterial vaginosis
Not Applicable
- Conditions
- Bacterial Vaginosis.Vaginitis, vulvitis and vulvovaginitis in infectious and parasitic diseases classified elsewhere
- Registration Number
- IRCT2015020320925N1
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- Not specified
Inclusion Criteria
(married;the age range between 30-18 years;no pregnant; IUD is not;during breastfeeding is not;Failure to perform hysterosalpangiography ,curettage and surgery of uterine in the past two weeks;absence of a history of sensitivity to oral metronidazole;broad-spectrum antibiotics and the immune system depressant drugs the past two weeks;lack of use of alcohol and anticoagulant drugs;absence of problems and anomalies of the cervix;the absence of pelvic inflammatory disease;the Absence of abnormal uterine bleeding (AUB or DUB) Exclusion criteria: Sensitivity to prescribed drug; take antibiotics (injectable, oral or vaginal) during the intervention; not using drug more than one time)
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amsel criteria. Timepoint: 7-10 days after treatment. Method of measurement: Three Amsel criteria (homogeneous gray discharge, positive Whiff test 5.4PH=).
- Secondary Outcome Measures
Name Time Method